Clinical Trials Directory

Trials / Completed

CompletedNCT04106791

Computer Assisted Vasopressor Titration in Critically Ill Patients

Evaluation of Closed-loop Control of Vasopressor Infusion in Critically Ill Patients: A Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Erasme University Hospital · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The purpose of this pilot study is to evaluate the performance of a novel closed-loop (automated) vasopressor administration system that delivers norepinephrine using feedback from standard operating room hemodynamic monitor (EV1000 Monitor-Flotrac Edwards Lifesciences, IRVINE, USA) in 10 to 12 critically ill patients in the intensive care unit.

Detailed description

The investigators have developed an automated closed-loop system for vasopressor administration . They will test it in critically ill patients. The investigators want to demonstrate that the closed-loop system can maintain mean arterial pressure ( MAP) within a very narrow range (within +/- 5 mmHg of the predefined MAP target) for more than 85 % of the treatment time. The Investigators have shown this to be the case in simulation studies and in-vivo animal studies and in surgical patients but not yet in the Intensive care unit (ICU). Investigators will recruit 10 to 12 ICU patients equipped with a mini-invasive cardiac output monitoring and under continuous norepinephrine infusion. These patients will typically include: septic patients, neuro ICU patients, ARDS patients, trauma patients or postoperative patients. The target MAP will be determined by the ICU physician in charge of the patient. Fluids will be given standard of care. The closed loop (automated) system will use an infusion pump (Q-Core and chemyx pump) and a controller (a computer run index and algorithm developed by Sironis) to make frequent, regular and accurate adjustments of vasopressor (norepinephrine) The goal is to register a period of two hours of closed-loop control of MAP.

Conditions

Interventions

TypeNameDescription
DEVICEclosed-loop system for vasopressor administrationThe closed-loop system' goal is to keep MAP within 5 mmHg of the predefined target MAP.

Timeline

Start date
2018-04-26
Primary completion
2018-09-30
Completion
2018-10-30
First posted
2019-09-27
Last updated
2019-11-18

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04106791. Inclusion in this directory is not an endorsement.